Week 15: Cannabinoids Flashcards
The main ROA for dronabinol is
A. I.M. B. Oral C. Inhalation D. Topical
oral
The route of administration of Sativex is
A. Oral B. Oral mucosal spray C. Inhalation D. Injection
Oral mucosal spray
The most ubiquitous receptors in the brain appear to be those responsive to
A. GABA B. Cannabinoids C. Glutamate D. NMDA
Cannabinoids
Marinol is a
A. Synthetic cannabinoid agonist
B. non-synthetic cannabinoid antagonist
C. non-synthetic cannabinoid agonist
D. synthetic cannabinoid antagonist
Synthetic cannabinoid agonist
Nabiximols is a
A. Non-synthetic cannabinoid agonist B. Synthetic cannabinoid agonist C. Non-synthetic cannabinoid antagonist D. Synthetic cannabinoid antagonist
Non-synthetic cannabinoid agonist
In California marijuana was legalized for non-medical use in
A. 1996 B. 2016 C. 2006 D. It is still not legal for non-medical use
2016
Which of the following is NOT an off-label use for Epidiolex?
A. Weight loss B. Pain relief C. Management of autism symptoms D. Anxiety
weight loss
In the US marijuana is currently listed under which DEA schedule?
Schedule I
Hashish and marijuana differ mainly in their
Potency
A primary indication for cannabidiol is
A. Seizure reduction B. Depression C. Antipyresis D. ADHD
Seizure reduction
In the US _______ states have legalized marijuana for either medical or recreational use.
A. 46
B. 48
C. 42
D. 44
46
THC can take up to 5 weeks to be completely excreted from the body because
A. It is eliminated in 4 phases B. It is highly lipid soluble C. It is metabolized in neurons D. It has very low protein binding
It is highly lipid soluble
Which of the following is NOT a primary indication of dronabinol?
A. Nausea/vomiting B. Anorexia C. Anxiety D. Appetite stimulation
anxiety
The major psychoactive ingredient in the marijuana plant is
A. Dronabinol B. Delta-9-tetrahydrocannabinol (THC) C. Cannabidiol D. Anandamide
Delta-9-tetrahydrocannabinol (THC)
epidiolex is a ______ at CB receptors
A. agonist
B. antagonist
C. inverse agonist
D. partial agonist
partial agonist